drugset / Trial / NCT03335436

Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

NCT03335436

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether a perioperative course of gabapentin in parturients on buprenorphine maintenance would improve analgesia after elective cesarean delivery (CD).

Timeline

Start
2018-04-01
Primary completion
2020-11
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 400 mg Oral

Indications

No indication recorded.